16-2830774-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000382280.8(ZG16B):c.133G>A(p.Val45Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000226 in 1,614,026 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000382280.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZG16B | NM_145252.3 | c.133G>A | p.Val45Ile | missense_variant | 3/4 | ENST00000382280.8 | NP_660295.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZG16B | ENST00000382280.8 | c.133G>A | p.Val45Ile | missense_variant | 3/4 | 1 | NM_145252.3 | ENSP00000371715 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152192Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000116 AC: 29AN: 249562Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135388
GnomAD4 exome AF: 0.000239 AC: 349AN: 1461834Hom.: 1 Cov.: 33 AF XY: 0.000226 AC XY: 164AN XY: 727214
GnomAD4 genome AF: 0.000105 AC: 16AN: 152192Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74340
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 25, 2023 | The c.241G>A (p.V81I) alteration is located in exon 3 (coding exon 3) of the ZG16B gene. This alteration results from a G to A substitution at nucleotide position 241, causing the valine (V) at amino acid position 81 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at